Nirsevimab Library
This is a collection of current resources related to Nirsevimab.
Impact of Nirsevimab Prophylaxis on Paediatric Respiratory Syncytial Virus (RSV)-Related Hospitalisations During the Initial 2023/24 Season in Luxembourg
2024
· European Centre for Disease Prevention and Control (ECDC),
· European Centre for Disease Prevention and Control (ECDC),
· Centre Hospitalier de Luxembourg
This study examines the impact of nirsevimab, a new antibody, on reducing RSV-related hospitalizations in Luxembourg during the 2023/24 season. After its introduction, neonatal coverage …
Ask aRCie